United Kingdom over the counter (OTC) drugs market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027. The market growth can be attributed to surging demands for the cold & flu medicines. Higher prices of branded drugs along with the growing prevalence of infectious diseases further drives the growth of the United Kingdom over the country (OTC) drugs market in the upcoming five years. Consistent research and advancement of the pharmaceutical industry coupled with the local manufacturing of the generic drugs also supports the growth of the United Kingdom over the counter (OTC) drugs market in the next five years.

Over the counter (OTC) drugs are the non-prescription based medicines that are usually sold without any legal prescription and are often with no side effects. These drugs are safe and do not have any addictive nature if consumed un-monitored or without physicians’ prescription. Although, as a general awareness the physicians often advise to consult doctors and experts regarding illness before self-prescribing any kind of medicine. Basic cold medicines, vitamin tablets, or health supplements are different categories of over the counter (OTC) drugs.

Expanding Pharmaceutical Industry Promises Market Growth

Surge in the demand for advanced medicine in affordable prices drive the growth of the United Kingdom over the counter (OTC) drugs market in the upcoming five years. In 2019, the annual turnover of pharmaceutical goods wholesalers in the UK was over USD63 billion. The pharmaceutical industry holds position among top 10 global industries for pharmaceutical products that accounts for over 2.5% of the global market. Imports of pharmaceutical products from other countries have considerably decreased in 2020 valued at USD20,871 million from USD23,458 million in the year 2019. Decreased imports points to increased research and development along with growing inclination of the consumers toward over the counter (OTC) drugs, thereby substantially supporting the growth of the United Kingdom over the counter (OTC) drugs market in the next five years.

Investments and Expenses Drives Market

Growing investments and rising expenses over the pharmaceutical products, and therapeutics in the country further supports the growth of the United Kingdom over the counter (OTC) drugs market in the future five years. Government is actively investing in the pharmaceutical industry to promote the local manufacturers along with rising expenditures by the consumers demanding for advanced & affordable pharmaceutical products, thereby aiding the growth of the United Kingdom over the counter (OTC) drugs market in the forecast years.


Click here to download the sample

Market Segmentation

The United Kingdom over the counter (OTC) drugs market is segmented by product, route of administration, dosage form, distribution channel, competitional landscape, and regional distribution. Based on product, the market is further segmented into cough, cold and flu; vitamins, mineral, and supplements (VMS); analgesics; gastrointestinal products; dermatology products; and others. By route of administration, the market is fragmented into oral, topical, and parenteral. Based on dosage form, the market is differentiated into tablets, capsules, liquids & solution, creams/lotions/ointments, and others. Based on distribution channel, the market is bifurcated into retail pharmacy, hospital pharmacy, and e-pharmacy. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside.

Company Profile

GlaxoSmithKline Plc., Novartis UK Limited, Sun Pharmaceuticals UK Limited, Johnson & Johnson Limited, Perrigo Company Plc., Reckitt Benckiser Plc., AstraZeneca Plc., among others is a partial list of major market players of the companies responsible for the growth of United Kingdom over the counter (OTC) drugs market.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Product

·         Route of Administration

·         Dosage Form

·         Distribution Channel

Regional scope

London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside

Key companies profiled

GlaxoSmithKline Plc., Novartis UK Limited, Sun Pharmaceuticals UK Limited, Johnson & Johnson Limited, Perrigo Company Plc., Reckitt Benckiser Plc., AstraZeneca Plc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, United Kingdom over the counter (OTC) drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • United Kingdom Over The Counter (OTC) Drugs Market, By Product:
    • Cough, Cold and Flu
    • Vitamins, Mineral, and Supplements (VMS)
    • Analgesics
    • Gastrointestinal Products
    • Dermatology Products
    • Others
  • United Kingdom Over The Counter (OTC) Drugs Market, By Route of Administration:
    • Oral
    • Topical
    • Parenteral
  • United Kingdom Over The Counter (OTC) Drugs Market, By Dosage Form:
    • Tablets
    • Capsules
    • Liquids & Solution
    • Creams/ Lotions/ Ointments
    • Others
  • United Kingdom Over The Counter (OTC) Drugs Market, By Distribution Channel:
    • Retail Pharmacy
    • Hospital Pharmacy
    • E-Pharmacy
  • United Kingdom Over The Counter (OTC) Drugs Market, By Region:

o   London

o   East Anglia

o   Southwest

o   Southeast

o   Scotland

o   East Midlands

o   Yorkshire & Humberside

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United Kingdom over the counter (OTC) drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).


United Kingdom Over the counter (OTC) drugs Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.     Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United Kingdom Over-The-Counter (OTC) Drugs Market

4.    Executive Summary

5.    Voice of Customers

6.    United Kingdom Over-The-Counter (OTC) Drugs Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others)

6.2.2.     By Route of Administration (Oral, Topical, Parenteral)

6.2.3.     By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)

6.2.4.     By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    United Kingdom Cough, Cold and Flu Over-The-Counter (OTC) Drugs Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Route of Administration

7.2.2.     By Dosage Form

7.2.3.     By Distribution Channel

8.    United Kingdom Vitamins, Mineral and Supplements (VMS) Over-The-Counter (OTC) Drugs Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Route of Administration

8.2.2.     By Dosage Form

8.2.3.     By Distribution Channel

9.    United Kingdom Analgesics Over-The-Counter (OTC) Drugs Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Route of Administration

9.2.2.     By Dosage Form

9.2.3.     By Distribution Channel

10.  United Kingdom Gastrointestinal Over-The-Counter (OTC) Drugs Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Route of Administration

10.2.2.  By Dosage Form

10.2.3.  By Distribution Channel

11.  United Kingdom Dermatology Over-The-Counter (OTC) Drugs Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Route of Administration

11.2.2.  By Dosage Form

11.2.3.  By Distribution Channel

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Policy & Regulatory Landscape

15.  United Kingdom Economic Profile

16.  Competitive Landscape

16.1.              GlaxoSmithKline Plc.

16.2.              Novartis UK Limited

16.3.              Sun Pharmaceuticals UK Limited

16.4.              Johnson & Johnson Limited

16.5.              Perrigo Company Plc.

16.6.              Reckitt Benckiser Plc.

16.7.              AstraZeneca Plc.

17.  Strategic Recommendations

                                                                                                           (Note: The companies list can be customized based on the client requirements.)

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com